OGEN

Oragenics, Inc.

Price Chart

No historical data available

Latest Quote

$0.51

-0.02 (-3.40%)

Current Price

Previous Close	$0.52
Open	$0.52
Day High	$0.53
Day Low	$0.49
Volume	94,158

Fetched: 2026-08-31T18:30:16

Stock Information

Shares Outstanding	4.51M
Cash Equivalents	$3.86M
Net Income	$-10.08M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$2.30M
P/E Ratio	0.54
EPS (TTM)	$0.95
Exchange	ASE

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Oragenics, Inc.

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.

📰 Latest News

No news articles available at the moment. Check back later for updates on OGEN.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Interest Expense	$785,930	$29,828	$30,591	$15,103
Total Expenses	$9,362,503	$10,558,815	$20,904,903	$14,420,768
Other Income Expense	$-13,193	$-25,172	$69,363	$11,582
Net Non Operating Interest Income Expense	$-603,701	$16,069	$179,803	$120,797
Interest Expense Non Operating	$785,930	$29,828	$30,591	$15,103
Operating Expense	$9,362,503	$10,558,815	$20,904,903	$14,420,768
General And Administrative Expense	$6,969,845	$6,444,381	$5,451,952	$4,479,605
Other Non Operating Income Expenses	-	-	$69,363	$11,582
Other Operating Expenses	-	-	$-37,653	$-131,521
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Net Interest Income	$-603,701	$16,069	$179,803	$120,797
Interest Income	$182,229	$45,897	$210,394	$135,900
Normalized Income	$-9,829,473	$-10,542,746	$-20,655,737	$-14,288,389
Net Income From Continuing And Discontinued Operation	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Total Operating Income As Reported	$-9,362,503	$-10,558,815	$-20,904,903	$-14,420,768
Net Income Common Stockholders	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Net Income	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Net Income Including Noncontrolling Interests	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Net Income Continuous Operations	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Pretax Income	$-9,979,397	$-10,567,918	$-20,655,737	$-14,288,389
Interest Income Non Operating	$182,229	$45,897	$210,394	$135,900
Operating Income	$-9,362,503	$-10,558,815	$-20,904,903	$-14,420,768
Per Share
Diluted EPS	$-4.56	$-47.88	$-275.40	$-213.30
Basic EPS	$-4.56	$-47.88	$-275.40	$-213.30
Other
Tax Effect Of Unusual Items	$-179	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-9,180,274	$-10,512,918	$-20,597,755	$-14,228,619
Total Unusual Items	$-13,193	$-25,172	-	-
Total Unusual Items Excluding Goodwill	$-13,193	$-25,172	-	-
EBITDA (Bullshit earnings)	$-9,193,467	$-10,538,090	$-20,597,755	$-14,228,619
EBIT	$-9,193,467	$-10,538,090	$-20,625,146	$-14,273,286
Diluted Average Shares	$2,157,076	$220,731	$74,989	$66,974
Basic Average Shares	$2,157,076	$220,731	$74,989	$66,974
Diluted NI Availto Com Stockholders	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Tax Provision	$-136,910	$0	$0	$0
Gain On Sale Of Security	$-13,193	$-25,172	-	-
Research And Development	$2,392,658	$4,114,434	$15,490,604	$10,072,684
Selling General And Administration	$6,969,845	$6,444,381	$5,451,952	$4,479,605
Other Gand A	$6,969,845	$6,444,381	$5,451,952	$4,479,605
Reconciled Depreciation	-	$0	$27,391	$44,667
Other Taxes	-	-	-	$5,140

Fetched: 2026-08-31

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$8,281,405	$-211,885	$3,168,154	$13,009,302
Total Assets	$10,067,764	$1,472,510	$4,966,335	$14,758,025
Total Non Current Assets	$0	$0	$1,100,561	$468,502
Current Assets	$10,067,764	$1,472,510	$3,865,774	$14,289,523
Other Current Assets	$1,614,956	$607,670	$382,273	$2,862,738
Receivables	$53,082	$0	-	$0
Accrued Interest Receivable	$53,082	$0	-	-
Cash Cash Equivalents And Short Term Investments	$8,399,726	$864,840	$3,483,501	$11,426,785
Cash And Cash Equivalents	$4,399,726	$864,840	$3,483,501	$11,426,785
Non Current Prepaid Assets	-	$0	$1,090,750	$0
Prepaid Assets	-	-	-	$2,862,738
Other Receivables	-	-	-	-
Debt
Total Debt	$227,348	$328,528	$322,514	$624,526
Current Debt And Capital Lease Obligation	$227,348	$328,528	$322,514	$472,087
Current Debt	$227,348	$328,528	$312,703	$267,640
Long Term Debt And Capital Lease Obligation	-	-	$0	$152,439
Liabilities
Total Liabilities Net Minority Interest	$1,786,359	$1,684,395	$1,798,181	$1,748,723
Total Non Current Liabilities Net Minority Interest	$0	$0	$0	$152,439
Current Liabilities	$1,786,359	$1,684,395	$1,798,181	$1,596,284
Current Notes Payable	$227,348	$328,528	$312,703	$267,640
Payables And Accrued Expenses	$1,559,011	$1,355,867	$1,467,686	$1,090,652
Payables	-	$1,144,634	$1,244,947	$246,690
Accounts Payable	-	$1,144,634	$1,244,947	$246,690
Equity
Common Stock Equity	$8,281,405	$-211,885	$1,575,431	$11,416,579
Total Equity Gross Minority Interest	$8,281,405	$-211,885	$3,168,154	$13,009,302
Stockholders Equity	$8,281,405	$-211,885	$3,168,154	$13,009,302
Retained Earnings	$-226,628,659	$-216,786,172	$-206,218,254	$-185,562,517
Preferred Stock Equity	-	-	$1,592,723	$1,592,723
Other
Ordinary Shares Number	$4,271,529	$419,003	$102,689	$67,488
Share Issued	$4,271,529	$419,003	$102,689	$67,488
Tangible Book Value	$8,281,405	$-211,885	$1,575,431	$11,416,579
Invested Capital	$8,508,753	$116,643	$1,888,134	$11,684,219
Working Capital	$8,281,405	$-211,885	$2,067,593	$12,693,239
Total Capitalization	$8,281,405	$-211,885	$3,168,154	$13,009,302
Additional Paid In Capital	$234,905,793	$216,573,868	$207,790,604	$196,977,071
Capital Stock	$4,271	$419	$1,595,804	$1,594,748
Common Stock	$4,271	$419	$3,081	$2,025
Preferred Stock	$0	$0	$1,592,723	$1,592,723
Other Short Term Investments	$4,000,000	$0	-	-
Capital Lease Obligations	-	$0	$9,811	$356,886
Current Capital Lease Obligation	-	$0	$9,811	$204,447
Pensionand Other Post Retirement Benefit Plans Current	-	$8,399	$7,981	$33,545
Current Accrued Expenses	-	$202,834	$222,739	$843,962
Net PPE	-	$0	$9,811	$468,502
Gross PPE	-	$0	$9,811	$1,831,741
Treasury Shares Number	-	-	$0	-
Long Term Capital Lease Obligation	-	-	$0	$152,439
Accumulated Depreciation	-	-	$0	$-1,363,239
Leases	-	-	$0	$487,871
Other Properties	-	-	$9,811	$1,024,184
Machinery Furniture Equipment	-	-	$0	$319,686
Properties	-	-	$0	$0

Fetched: 2026-08-31

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-9,246,387	$-8,597,382	$-8,290,880	$-15,356,002
Operating Activities
Operating Cash Flow	$-9,246,387	$-8,597,382	$-7,290,880	$-15,228,483
Cash Flow From Continuing Operating Activities	$-9,246,387	$-8,597,382	$-7,290,880	$-15,228,483
Operating Gains Losses	-	-	$29,956	$-10,964
Investing Activities
Investing Cash Flow	-	$0	$-936,284	$-115,519
Cash Flow From Continuing Investing Activities	-	$0	$-936,284	$-115,519
Capital Expenditure	-	-	$-1,000,000	$-127,519
Financing Activities
Issuance Of Capital Stock	$17,653,890	$6,671,830	$849,926	$69,289
Financing Cash Flow	$16,781,273	$5,978,721	$283,880	$-494,916
Cash Flow From Continuing Financing Activities	$16,781,273	$5,978,721	$283,880	$-494,916
Net Preferred Stock Issuance	$15,019,700	$0	-	$0
Preferred Stock Issuance	$15,019,700	$0	-	-
Net Common Stock Issuance	$2,634,190	$6,671,830	$849,926	$69,289
Common Stock Issuance	$2,634,190	$6,671,830	$849,926	$69,289
Repurchase Of Capital Stock	-	-	-	$0
Other
Repayment Of Debt	$-3,328,528	$-693,109	$-566,046	$-564,205
Issuance Of Debt	$2,455,911	$0	$0	$0
Interest Paid Supplemental Data	$22,353	$29,828	$30,591	$9,290
End Cash Position	$8,399,726	$864,840	$3,483,501	$11,426,785
Beginning Cash Position	$864,840	$3,483,501	$11,426,785	$27,265,703
Changes In Cash	$7,534,886	$-2,618,661	$-7,943,284	$-15,838,918
Net Issuance Payments Of Debt	$-872,617	$-693,109	$-566,046	$-564,205
Net Short Term Debt Issuance	$-872,617	$-693,109	$-566,046	$-564,205
Short Term Debt Payments	$-3,328,528	$-693,109	$-566,046	$-564,205
Short Term Debt Issuance	$2,455,911	$0	$0	$0
Change In Working Capital	$-857,224	$1,454,487	$2,017,176	$-1,716,000
Change In Other Current Liabilities	$0	$-9,811	$-347,075	-
Change In Other Current Assets	$0	$9,811	$337,629	$0
Change In Payables And Accrued Expense	$203,144	$-119,800	$25,798	$176,625
Change In Prepaid Assets	$-1,007,286	$1,574,287	$2,000,824	$-1,899,612
Change In Receivables	$-53,082	$0	$0	$6,987
Other Non Cash Items	$897,577	-	$10,273,506	-
Stock Based Compensation	$555,747	$516,049	$1,016,828	$742,203
Net Income From Continuing Operations	$-9,842,487	$-10,567,918	$-20,655,737	$-14,288,389
Net Intangibles Purchase And Sale	-	$0	$-1,000,000	$0
Purchase Of Intangibles	-	$0	$-1,000,000	$0
Net PPE Purchase And Sale	-	$0	$63,716	$-115,519
Sale Of PPE	-	$0	$63,716	$12,000
Depreciation Amortization Depletion	-	$0	$27,391	$44,667
Depreciation And Amortization	-	$0	$27,391	$44,667
Gain Loss On Sale Of PPE	-	$0	$29,956	$-10,964
Purchase Of PPE	-	-	$0	$-127,519
Proceeds From Stock Option Exercised	-	-	-	$0
Preferred Stock Payments	-	-	-	$0

Fetched: 2026-08-31